[1]
|
葛均波, 徐永健. 内科学[M]. 第8版. 北京: 人民卫生出版社, 2019: 87-98.
|
[2]
|
刘庆伟, 邵美华, 赵亚玲, 尹霄朦, 姜园园, 朱秀丽. 间质性肺疾病患者生活质量现状及影响因素研究[J]. 中国慢性病预防与控制, 2021, 29(3): 201-205.
|
[3]
|
方高洁, 胡娟. 肿瘤标记物CEA、SCCA、CYFRA21-1联合NSE检测对肺癌的诊断价值分析[J]. 实用癌症杂志, 2019, 34(7): 1161-1163+1175.
|
[4]
|
杨嫄, 郝景程, 陈媛, 刘毅, 谢其冰, 尹耕. 肿瘤相关标志物在皮肌炎合并间质性肺病患者中的意义[J]. 四川大学学报(医学版), 2018, 49(2):195-199.
|
[5]
|
Sargin, G., Köse, R. and Şentürk, T. (2018) Tumor-Associated Antigens in Rheumatoid Arthritis Interstitial Lung Disease or Malignancy? Archives of Rheumatology, 33, 431-437. https://doi.org/10.5606/ArchRheumatol.2018.6691
|
[6]
|
林蕊艳, 张新, 李晓辉, 胥振扬. 间质性肺疾病血清肿瘤标记物升高的临床意义[J]. 中国临床药理学杂志, 2011, 27(8): 623-625.
|
[7]
|
朱杰. 肺特发性间质性肺炎与结缔组织病相关性间质性肺疾病的比较分析[J]. 基层医学论坛, 2019, 23(13): 1840-1841.
|
[8]
|
杨红娇, 董昭兴, 王颖. 特发性肺纤维化生物标志物的研究进展[J]. 中国呼吸与危重监护杂志, 2019, 18(2): 204-208.
|
[9]
|
魏文静, 任钰荣, 发如克·帕尔哈提, 李风森. 间质性肺疾病与肿瘤标志物相关性的研究进展[J]. 新疆中医药, 2018, 36(6): 86-89.
|
[10]
|
Calabrese, F., Lunardi, F., Giacometti, C., Marulli. G., Gnoato, M., Pontisso, P., et al. (2008) Overexpession of Squamous Cell Carcinoma Antigen in Idiopathic Pulmonary Fibrosis: Clinicopathological Correlation. Thorax, 63, 795-802.
https://doi.org/10.1136/thx.2007.088583
|
[11]
|
Molina, R., Auge, J.M., Escudero, J.M., Marrades, R., Viñolas, N., Carcereny, E., et al. (2008) Mucins CA 125, CA 19.9, CA 15.3 and TAG-72.3 as Tumor Markers in Patients with Lung Cancer: Comparison with CYFRA 21-1, CEA, SCC and NSE. Tumor Biology, 29, 371-380. https://doi.org/10.1159/000181180
|
[12]
|
Totani, Y., Saito, Y., Miyachi, H., Shimizu, H., Hoshino, T., Hayashi, M., et al. (2005) Clinical Characterization of CA19-9 in Patients with Interstitial Pneumonia Showing Pathological Nonspecific Interstitial Pneumonia Patter. Nihon Kokyuki Gakkai Zasshi, 43, 77-83.
|
[13]
|
Wells, A.U. and Hirani, N. (2008) Interstitial Lung Disease Guideline. Thorax, 63, v1-v58.
https://doi.org/10.1136/thx.2008.101691
|
[14]
|
Shiels, M.S., Katki, H.A., Freedman, N.D., Purdue, M.P., Wentzensen, N., Trabert, B., et al. (2014) Cigarette Smoking and Variations in Systemic Immune and Inflammation Markers. Journal of the National Cancer Institute, 106, dju294.
https://doi.org/10.1093/jnci/dju294
|
[15]
|
Crotty Alexander, L.E., Shin, S. and Hwang, J.H. (2015) Inflammatory Diseases of the Lung Induced by Conventional Cigarette Smoke: A Review. Chest, 148, 1307-1322. https://doi.org/10.1378/chest.15-0409
|
[16]
|
Wong, A.W., Lee, T.Y., Johannson, K.A., Assayag, D., Morisset, J., Fell, C.D., et al. (2020) A Cluster-Based Analysis Evaluating the Impact of Comorbidities in Fibrotic Interstitial Lung Disease. Respiratory Research, 21, Article No. 322.
https://doi.org/10.1186/s12931-020-1296-3
|
[17]
|
刘志华, 卢旭妹, 容亓. 血清标志物CYFRA21-1、SCC、NSE、CEA及ProGRP联合检测在非小细胞性肺癌中的诊断价值[J]. 河北医药, 2019, 41(10): 1464-1468.
|
[18]
|
Wang, J., Chu, Y., Li, J., Zeng, F., Wu, M., Wang, T., et al. (2020) Development of a Prediction Model with Serum Tumor Markers to Assess Tumor Metastasis in Lung Cancer. Cancer Medicine, 9, 5436-5445.
https://doi.org/10.1002/cam4.3184
|
[19]
|
Matsubara, Y., Iwashita, T., Ishimatsu, Y., Shikuwa, C., Kadota, J. and Kohno, S. (2000) Evaluation of CYFRA 21-1 and ProGRP in Serum and Bronchoalveolar Lavage Fluid of Patients with Benign Lung Disease. Nihon Kokyuki Gakkai Zasshi, 38, 659-664.
|
[20]
|
Suzuki, A., Masuda, T., Koito, N., Suzuki, T., Mita, S., Matsuoka, Y., et al. (1996) Studies of Serum Markers in Patients with Interstitial Pneumonia/Pulmonary Fibrosis Complicated with Collagen Diseases: Clinical Evaluation of CYFRA21-1. Ryumachi, 36, 837-843.
|
[21]
|
Zheng, M., Lou, A., Zhang, H., et al. (2021) Serum KL-6, CA19-9, CA125 and CEA Are Diagnostic Biomarkers for Rheumatoid Arthritis-Associated Interstitial Lung Disease in the Chinese Population. Rheumatology and Therapy, 8, 517-527. https://doi.org/10.1007/s40744-021-00288-x
|
[22]
|
Wang, T., Zheng, X.J., Ji, Y.L., Liang, Z.-A. and Liang, B.-M. (2016) Tumour Markers in Rheumatoid Arthritis-Associated Interstitial Lung Disease. Clinical and Experimental Rheumatology, 34, 587-591.
|
[23]
|
Dai, H., Liu, J., Liang, L., Ban, C., Jiang, J., Liu, Y., et al. (2014) Increased Lung Cancer Risk in Patients with Interstitial Lung Disease and Elevated CEA and CA125 Serum Tumour Markers. Respirology, 19, 707-713.
https://doi.org/10.1111/resp.12317
|
[24]
|
Kodama, T., Satoh, H., Ishikawa, H. and Ohtsuka, M. (2007) Serum Levels of CA19-9 in Patients with Nonmalignant Respiratory Diseases. Journal of Clinical Laboratory Analysis, 21, 103-106. https://doi.org/10.1002/jcla.20136
|
[25]
|
Mukae, H., Sakito, O., Oda, H., Senju, R., Fukushima, K., Hiratani, K., et al. (1991) Two Cases of Interstitial Pneumonitis with Marked Increase of Tumor-Associated Carbohydrate Antigens in Serum. Nihon Kyobu Shikkan Gakkai Zasshi, 29, 611-617.
|
[26]
|
龚岚, 罗晓云. CEA、CY211、NSE、Ca125联合诊断肺癌的ROC曲线分析[J]. 中华肺部疾病杂志(电子版), 2020, 13(6): 777-780.
|